Draft Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings, 34146-34147 [2010-14492]

Download as PDF 34146 Federal Register / Vol. 75, No. 115 / Wednesday, June 16, 2010 / Notices Dated: June 9, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2010–14445 Filed 6–15–10; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed Collection; Comment Request Resource for the Collection and Evaluation of Human Tissues and Cells From Donors With an Epidemiology Profile (NCI) SUMMARY: In compliance with the requirement of Section 3506(c) (2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Cancer Institute (NCI), the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. Proposed Collection: Title: Resource for the Collection and Evaluation of Human Tissues and Cells From Donors With an Epidemiology Profile (NCI). Type of Information Collection Request: New. Need and Use of Information Collection: Under the auspices of three NCI IRB-approved protocols and instruments, the Laboratory of Human Carcinogenesis conducts case-control studies to investigate the relations between biomarkers, the environment, and human cancer. Human subjects recruited from the general population are needed as controls (Population Controls) for bio-specimens and personal histories (social, occupational and health) that serve as references for the significance of the frequency and prevalence of bio-markers found in cancer patients and thought to be important in the development, progression, and/or response to treatment of the malignant growths in cancer patients. The questionnaires will be used to obtain the personal histories to compare to the life styles and exposures and the biospecimens will serve as controls for the assay results obtained from cancer patients. The collection of information and specimens from the cancer cases received NIH Clinical Exemption (Request #2009–09– 002) on October 28, 2009. Frequency of Response: Once. Affected Public: Adult and senior members of the licensed driver population in Baltimore, Maryland and eleven nearby counties, including the Eastern Shore. Type of Respondents: Responders will be English speaking, male and female, Caucasian, African-American and Asian. The total annual reporting burden is estimated to be 692 (see table below). There are no Capital Costs, Operating Costs, and/or Maintenance Costs to report. TABLE 1—ESTIMATES OF ANNUAL BURDEN HOURS Type of respondents Survey instrument Adults (40–79 years old) ................ Telephone Screener (Attachment 16). Main Questionnaire (Attachment 6) Prostate Supplemental Questionnaire (Attachment 7). Liver Supplement (Attachment 8) .. Refusal Questionnaire Form (Attachment 21). 1700 225 125 ......................................................... sroberts on DSKD5P82C1PROD with NOTICES Request for Comments: Written comments and/or suggestions from the public and affected agencies should address one or more of the following points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. FOR FURTHER INFORMATION CONTACT: To 16:19 Jun 15, 2010 Jkt 220001 1 1 10/60 (0.17) 60/60 (1) 30/60 (0.5) 225 63 1 1 30/60 (0.5) 2/60 (0.03) 113 8 2500 ........................ ............................ 692 proposed project or to obtain a copy of the data collection plans and instruments, contact Glenwood E. Trivers or Elise Bowman, Center for Cancer Research, NCI, NIH, 37 Convent Drive, Room 3060–C or 3060–A, Building 37, Bethesda, Maryland 30893–4258 or call non-toll-free number 301–496–2094 or 301–496–2090 or email your request, including your address to triversg@mail.nih.gov or bowmane@mail.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Dated: June 9, 2010. Vivian Horovitch-Kelley, NCI Project Clearance Liaison, National Institutes of Health. [FR Doc. 2010–14546 Filed 6–15–10; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00054 Fmt 4703 Annual burden hours 225 225 request more information on the VerDate Mar<15>2010 Frequency of response Average time per response (minutes/hour) 1 Totals ....................................... Number of respondents Sfmt 4703 283 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Draft Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (DHHS). ACTION: Notice of availability and request for public comment. SUMMARY: This notice is a request for review of and comment on the Draft Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings, available on the following Web site: https://www.cdc.gov/publiccomments/. This document is for use by infection prevention staff, healthcare epidemiologists, healthcare administrators, nurses, other healthcare E:\FR\FM\16JNN1.SGM 16JNN1 34147 Federal Register / Vol. 75, No. 115 / Wednesday, June 16, 2010 / Notices providers, and persons responsible for developing, implementing, and evaluating infection prevention and control programs for healthcare settings across the continuum of care. This guideline provides evidence-based recommendations for prevention and control of norovirus outbreaks in healthcare settings. DATES: Comments must be received on or before July 16, 2010. ADDRESSES: Comments on the Draft Guideline should be submitted by email to HCNoro@cdc.gov or by mail to CDC, Division of Healthcare Quality Promotion, Attn: Michelle King, 1600 Clifton Rd., NE, Mailstop A–07, Atlanta, Georgia, 30333; or by fax 404–639–4049. All comments received will be posted electronically for viewing at: https:// www.cdc.gov/publiccomments/. FOR FURTHER INFORMATION CONTACT: Michelle King, HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road, NE., Mailstop A–07, Atlanta, Georgia 30333, Telephone: (404) 639–2936, E-mail: HICPAC@cdc.gov. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call) Contact Person: Carol J. Goter-Robinson, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 748, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7791, goterrobinsonc@extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) NC 27709, (919) 541–1307, bass@niehs.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: June 10, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–14548 Filed 6–15–10; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Reimbursement Rates for Calendar Year 2010 Dated: June 10, 2010. Tanja Popovic, Deputy Associate Director of Science Centers for Disease Control and Prevention. National Institutes of Health AGENCY: [FR Doc. 2010–14492 Filed 6–15–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health sroberts on DSKD5P82C1PROD with NOTICES National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Biomarkers in Acute Kidney Injury Ancillary Studies. Date: July 28, 2010. Time: 4 p.m. to 5 p.m. VerDate Mar<15>2010 16:19 Jun 15, 2010 Jkt 220001 [FR Doc. 2010–14551 Filed 6–15–10; 8:45 am] BILLING CODE 4140–01–P Dated: June 9, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy, BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service National Institute of Environmental Health Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel, Pathway to Independence/ Career Development. Date: July 19, 2010. Time: 1:30 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: NIEHS/National Institutes of Health, Building 4401, East Campus, 79 T.W. Alexander Drive, Research Triangle Park, NC 27709 (Telephone Conference Call). Contact Person: Linda K. Bass, PhD, Scientific Review Administrator, Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute Environmental Health Sciences, P.O. Box 12233, MD EC–30, Research Triangle Park, PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 ACTION: Indian Health Service, HHS. Notice. SUMMARY: Notice is given that the Director of Indian Health Service (IHS), under the authority of sections 321(a) and 322(b) of the Public Health Service Act (42 U.S.C. 248 and 249(b)), Public Law 83–568 (42 U.S.C. 2001(a)), and the Indian Health Care Improvement Act (25 U.S.C. 1601 et seq.), has approved the following rates for inpatient and outpatient medical care provided by IHS facilities for Calendar Year 2010 for Medicare and Medicaid beneficiaries and beneficiaries of other Federal programs. The Medicare Part A inpatient rates are excluded from the table below as they are paid based on the prospective payment system. Since the inpatient rates set forth below do not include all physician services and practitioner services, additional payment may be available to the extent that those services meet applicable requirements. Section 1880 of the Social Security Act authorizes Medicare Part B payment to hospitals and ambulatory care clinics operated by IHS or by an Indian Tribe or Tribal organization. Calendar Year 2010 Inpatient Hospital Per Diem Rate (Excludes Physician/Practitioner Services) Lower 48 States ....................... Alaska ....................................... E:\FR\FM\16JNN1.SGM 16JNN1 $2,046 2,246

Agencies

[Federal Register Volume 75, Number 115 (Wednesday, June 16, 2010)]
[Notices]
[Pages 34146-34147]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-14492]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Draft Guideline for the Prevention and Control of Norovirus
Gastroenteritis Outbreaks in Healthcare Settings

AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (DHHS).

ACTION: Notice of availability and request for public comment.

-----------------------------------------------------------------------

SUMMARY: This notice is a request for review of and comment on the
Draft Guideline for the Prevention and Control of Norovirus
Gastroenteritis Outbreaks in Healthcare Settings, available on the
following Web site: https://www.cdc.gov/publiccomments/.
This document is for use by infection prevention staff, healthcare
epidemiologists, healthcare administrators, nurses, other healthcare

[[Page 34147]]

providers, and persons responsible for developing, implementing, and
evaluating infection prevention and control programs for healthcare
settings across the continuum of care. This guideline provides
evidence-based recommendations for prevention and control of norovirus
outbreaks in healthcare settings.

DATES: Comments must be received on or before July 16, 2010.

ADDRESSES: Comments on the Draft Guideline should be submitted by e-
mail to HCNoro@cdc.gov or by mail to CDC, Division of Healthcare
Quality Promotion, Attn: Michelle King, 1600 Clifton Rd., NE, Mailstop
A-07, Atlanta, Georgia, 30333; or by fax 404-639-4049. All comments
received will be posted electronically for viewing at: https://www.cdc.gov/publiccomments/.

FOR FURTHER INFORMATION CONTACT: Michelle King, HICPAC, Division of
Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road, NE.,
Mailstop A-07, Atlanta, Georgia 30333, Telephone: (404) 639-2936, E-
mail: HICPAC@cdc.gov.

Dated: June 10, 2010.
Tanja Popovic,
Deputy Associate Director of Science Centers for Disease Control and
Prevention.
[FR Doc. 2010-14492 Filed 6-15-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.